Literature DB >> 15902682

Regulation of murine chronic colitis by CD4+CD25- programmed death-1+ T cells.

Teruji Totsuka1, Takanori Kanai, Shin Makita, Rei Fujii, Yasuhiro Nemoto, Shigeru Oshima, Ryuichi Okamoto, Akemi Koyanagi, Hisaya Akiba, Ko Okumura, Hideo Yagita, Mamoru Watanabe.   

Abstract

Naturally arising CD4(+)CD25(+) regulatory T (T(R)) cells are engaged in the maintenance of self tolerance and prevention of autoimmune diseases. However, accumulating evidence suggests that a fraction of peripheral CD4(+)CD25(-) T cells also possesses regulatory activity. Programmed death-1 (PD-1) is a new member of the CD28/CTLA-4 family, which has been implicated in the maintenance of peripheral self tolerance. Here, we identified a subpopulation of CD4(+)CD25(-)PD-1(+) T cells in the spleen of naive mice that constitutively expressed CTLA-4 and FoxP3 and was hypoproliferative in response to anti-CD3 antibody stimulation in vitro. However, the CD4(+)CD25(-)PD-1(+) T cells uniquely produced large amounts of IL-4 and IL-10 in response to anti-CD3 and anti-CD28 mAb stimulation, unlike the CD4(+)CD25(+) T(R) cells. The CD4(+)CD25(-)PD-1(+) T cells exhibited a suppressor activity against the proliferation of anti-CD3 antibody-stimulated CD4(+)CD25(-)PD-1(-) T cells in vitro, which was partially abrogated by anti-CTLA-4 mAb, but not by anti-IL-10 or anti-PD-1 mAb. Remarkably, the CD4(+)CD25(-)PD-1(+) T cells inhibited the development of colitis induced by adoptive transfer of CD4(+)CD45RB(high) T cells into C.B17-scid/scid mice, albeit to a lesser extent than CD4(+)CD25(+) T(R) cells, in a CTLA-4-dependent manner. These results indicate that the CD4(+)CD25(-)PD-1(+) T cells contain substantial amounts of T(R) cells that are involved in the maintenance of peripheral tolerance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902682     DOI: 10.1002/eji.200425109

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  NLRX1 Regulates Effector and Metabolic Functions of CD4+ T Cells.

Authors:  Andrew Leber; Raquel Hontecillas; Nuria Tubau-Juni; Victoria Zoccoli-Rodriguez; Matthew Hulver; Ryan McMillan; Kristin Eden; Irving C Allen; Josep Bassaganya-Riera
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

2.  Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: A systematic review and meta-analysis.

Authors:  Daniel Y Wang; Fei Ye; Shilin Zhao; Douglas B Johnson
Journal:  Oncoimmunology       Date:  2017-07-05       Impact factor: 8.110

3.  In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors.

Authors:  Danny N Khalil; Nathan Suek; Luis Felipe Campesato; Sadna Budhu; David Redmond; Robert M Samstein; Chirag Krishna; Katherine S Panageas; Marinela Capanu; Sean Houghton; Daniel Hirschhorn; Roberta Zappasodi; Rachel Giese; Billel Gasmi; Michael Schneider; Aditi Gupta; James J Harding; John Alec Moral; Vinod P Balachandran; Jedd D Wolchok; Taha Merghoub
Journal:  J Clin Invest       Date:  2019-07-22       Impact factor: 14.808

4.  Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo.

Authors:  Simon Read; Rebecca Greenwald; Ana Izcue; Nicholas Robinson; Didier Mandelbrot; Loise Francisco; Arlene H Sharpe; Fiona Powrie
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

Review 5.  Genes, tolerance and systemic autoimmunity.

Authors:  Ram P Singh; Richard T Waldron; Bevra H Hahn
Journal:  Autoimmun Rev       Date:  2011-11-30       Impact factor: 9.754

Review 6.  The PD-1 pathway in tolerance and autoimmunity.

Authors:  Loise M Francisco; Peter T Sage; Arlene H Sharpe
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

Review 7.  Disrupted regulatory T cell homeostasis in inflammatory bowel diseases.

Authors:  Christophe Pedros; Fanny Duguet; Abdelhadi Saoudi; Marianne Chabod
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

8.  Cutting Edge: Responder T cells regulate human DR+ effector regulatory T cell activity via granzyme B.

Authors:  Charles W Ashley; Clare Baecher-Allan
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

9.  CD4+CD25+Tregs express an increased LAG-3 and CTLA-4 in anterior chamber-associated immune deviation.

Authors:  Xuefei Zhu; Peizeng Yang; Hongyan Zhou; Bing Li; Xiangkun Huang; Qianli Meng; Li Wang; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-31       Impact factor: 3.117

Review 10.  Immunosuppressive Mechanisms of Regulatory B Cells.

Authors:  Diego Catalán; Miguel Andrés Mansilla; Ashley Ferrier; Lilian Soto; Kristine Oleinika; Juan Carlos Aguillón; Octavio Aravena
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.